Reumatizam, Vol. 58 No. 1, 2011.
Izvorni znanstveni članak
The role of anti-cyclic citrullinated peptide antibodies in predicting rheumatoid arthritis
Sylejman Rexhepi
orcid.org/0000-0003-4839-9906
; Department of Rheumatology, Clinic for Internal Medicine, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo
Mjellma Rexhepi
; Department of Rheumatology, Clinic for Internal Medicine, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo
Vjollca Sahatçiu-Meka
; Physical Medicine Department, Faculty of Medicine, University of Prishtina, Prishtina, Kosovo
Argjend Tafaj
; Rheumatology Department, Faculty of Medicine, University of Tirana, Tirana, Albania
Remzi Izairi
; Faculty of Medicine, State University of Tetova, Tetova, Macedonia
Blerta Rexhepi
; Faculty of Medicine, University of Prishtina, Prishtina, Kosovo
Sažetak
The study presents the results of predicting role of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis, compared to rheumatoid factor. 32 patients with rheumatoid arthritis were identified from a retrospective chart review.
The results of our study show that presence of the rheumatoid factor has less diagnostic and prognostic significance than the anti-cyclic citrullinated peptide, and suggests its superiority in predicting an erosive disease course.
Ključne riječi
rheumatoid arthritis; anti-cyclic citrullinated peptide antibody; rheumatoid factor
Hrčak ID:
124553
URI
Datum izdavanja:
1.6.2011.
Posjeta: 1.071 *